Welcome

Life sciences, pharma and biotech

Welcome to Europe's hottest event for life sciences, pharma and biotech.

Why attend HLTH Europe?

As Europe’s most important health event, HLTH Europe will unite every part of the European health ecosystem.

Connecting over 3,500 health leaders from over 50 countries, HLTH Europe will bring together key decision-makers across providers, payers, government, pharma, startups, investors and health tech. With one in three attendees at C-level and two in three at Director level (or equivalent), HLTH Europe is the place where health does business.

With a focus on life sciences and the ever-growing role that the sector plays in health revolution, HLTH Europe will be an innovation showcase for life sciences, pharma, biotech. Whether you’re looking for your next partner, want to showcase your solutions or scale across markets, HLTH Europe is the only place you need to be in 2024.

Must attend pharma sessions

Thrills, pills, and VC bills: What will it take to unleash innovation in the world of drug development

Drug development and rapid innovation are unlikely bedfellows.

Drug development is, by its very nature, a long-winded, wieldy, hyper-expensive process. However, the integration of artificial intelligence, high-throughput screening techniques, and advanced computational modelling has catalysed the identification of potential drug candidates and expedited the prediction of their efficacy and safety profiles.

Are we finally entering an era where the once-distant notions of drug development and rapid innovation are becoming increasingly intertwined? And what will it take for the industry to fully harness the potential of novel tools and strategies to address unmet medical needs in a more efficient and agile manner?

Inclusive clinical trials: Why we really shouldn't still be talking about this in 2024 (but have to!)

In 2022, the US’s National Academy of Sciences, Engineering & Medicine (NASEM) released a damning report into underrepresentation in clinical trials.

"While progress has been made with representation of white women in clinical trials and clinical research, there has been little progress in the last three decades to increase participation of racial and ethnic minority population groups."

Whilst we celebrate diversity in Europe, from race to gender, sexuality to age, participants in clinical trials remain overwhelmingly white and male. However, until interest and investment to improve diversity and representativeness in trials comes to the forefront, the goals of diversification remain poorly articulated and understood.

We all know how important diversity is, but how exactly can we make clinical trials attractive to all?

Dr. Google will see you now: Improving patient education or miseducating the masses?

We’ve all done it.

You get an odd rash, or a strange pain in your back, and off to the internet you go.

But googling your symptoms only tells you which diseases have the best SEO. There are pros and cons to googling your symptoms (or Binging them, if you’re really alternative), but in this interconnected world, where access remains an issue, the number of people doing it will continue to rise.

How can we ensure that search engines prioritise accurate, accessible, and up-to-date health information, and steer those in need away from misinformation?

Dr. Google will always be faster and more accessible than traditional healthcare systems. Maybe, in fact, search engines are exactly what the doctor ordered.

Decode, detect, and defy: Expectations for digital biomarkers

In the past, the idea that technology could offer earlier detection and prevention of diseases, unparalleled insights into diseases currently not tracked well with diagnostic tests, and improved patient engagement, safety and quality of care, would have been laughable.

On the face of it, digital biomarkers are the holy grail, beautifully blurring the patient-consumer boundary, and providing clinicians with previously inconceivable levels of monitoring and data, and patients a level of health autonomy never previously possible. But there is no perfect fit.

Lack of precision, gaps in both evidence requirements and economic models, and questions around data ownership abound. Can digital biomarkers rise up to the expectations?

Speaker highlights for pharma

David Evendon-Challis

Head of R&D and Chief Scientific Officer

Bayer Consumer Health

Switzerland

John Halamka

President, Mayo Clinic Platform

Mayo Clinic

USA

Karen DeSalvo

Chief Health Officer

Google

USA

Karen Madden

Chief Technology Officer

Merck Life Science

USA

Simon Turner

Partner

Sofinnova Partners

France

Stephen Ranjan

Global Head, Digital Health Pharma Personalized Healthcare

Roche

Switzerland

PHARMA CONNECT

Get a free ticket & €750 travel budget

Pharma Connect helps innovation leaders in pharma, responsible for decision-making and influence - explore solutions and services that address their most pressing challenges.

Double opt-in, 15-minute meetings match your organisational needs with the right vendor, so you can discover and evaluate solutions efficiently.

Take 8 meetings and get a free ticket to HLTH Europe. Take 12 meetings and we'll reimburse up to €750 of your travel and hotel costs.


Special programming

Unlock unparalleled networking opportunities, learn from your peers and explore the biggest advances in health.

Pharma Connect

Attend HLTH Europe free of charge, plus get a €750 travel reimbursement.

The Pharma Connect Programme is our 1:1 matchmaking programme that pairs leaders looking for health solutions with the companies that provide the answer to their challenges.

Pharma leaders are invited to apply to attend for free, in exchange for taking 8, 15-minute meetings. With over 45 hours of sessions, programming, networking and parties, that's just 5% of your HLTH Europe experience!

If you take 12+ meetings, we'll reimburse your travel too, up to €750.

Invite-only medical centre tours

Head offsite at HLTH Europe and discover Amsterdam’s world-renowned medical centres first-hand.

Our exclusive tours give you the unique opportunity to explore Amsterdam's leading healthcare institutions and innovative medical facilities. Engage in guided tours, discussions with healthcare leaders, and see cutting-edge medical technologies and research up close. 

Pharma networking dinners

Enjoy an exclusive hosted multi-course meal at one of Amsterdam's finest restaurants.

We've reserved tables at some of Amsterdam's finest restaurants, exclusively for our leaders in pharma.

The ideal way to unwind after a busy day at HLTH Europe, our networking dinners gather intimate groups of like-minded leaders, to meet, mingle and enjoy the finest of dining options Amsterdam has to offer.

Dinners are invite-only, so if you're interested in getting involved, email us below to register your interest.

Discover the pharma agenda

With over 80 sessions and 300 speakers, we want to make sure you don't miss the most important sessions and programming for lifescience, pharma and biotech. We've created a pharma-specific agenda, so you can plan your HLTH Europe experience effectively.

Party with us!

Some call it our forte, others call it the secret sauce - but one thing's for sure, our legendary parties are the pinnacle of the HLTH experience.

Monday

WELCOME RECEPTION

7.30 PM

Tuesday

BEACH SOCIAL

5.45 PM

Wednesday

HLTHFEST

7 PM

Thursday

SURVIVORS' BBQ

12.30 PM

What's included with your ticket?

  • Access to all track and keynote sessions

  • HLTH Europe event app and attendee networking programme

  • All networking events, affinity meetups and receptions

  • All-inclusive breakfasts, lunches and refreshments throughout the day

  • Exhibit hall access, plus a full exhibitor directory

  • World-class entertainment, parties and live performances

  • Incredible memories, lasting connections and 3,500 new friends*


    *Number of new friends not guaranteed, but highly expected

Your next step

Secure your ticket now. The earlier you book, the lower the rate!

About HLTH Europe


hlth.

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

EUROPE


2024 | HLTH Europe: 17-20 JUNE
2025 | HLTH Europe: 16-19 JUNE
2026 | HLTH Europe: 15-18 JUNE
2027 | HLTH Europe: 21-24 JUNE
2028 | HLTH Europe: 19-22 JUNE

USA


2024 | ViVE: Feb 25-28

2024 | HLTH US: Oct 19-22

2025 | ViVE: Feb 16-19

2025 | HLTH US: Nov 15-18

2026 | HLTH US: Oct 17-20


Join the HLTH Europe mailing list